Abstract:The intratumoral microbiota can modulate the tumor immune microenvironment (TIME), however, the underlying mechanism by which intratumoral microbiota influences the TIME in urothelial carcinoma of bladder (UCB) remains unclear. To address this, we collected 402 patients with UCB with paired host transcriptome and tumor microbiome samples from The Cancer Genome Atlas (TCGA). We found that the intratumoral microbiome profiles were significantly correlated with the expression pattern of epithelial-mesenchymal transition (EMT)-related genes. Furthermore, we detected that the genus Lachnoclostridium and Sutterella in tumors could indirectly promote EMT program by inducing an inflammatory response. Moreover, the inflammatory response induced by these two intratumoral bacteria further enhanced intratumoral immune infiltration, affecting patient survival and response to immunotherapy. In addition, an independent immunotherapy cohort of 348 patients with bladder cancer was used to validate our results. Collectively, our study elucidates the potential mechanism by which the intratumoral microbiota influences the TIME of UCB and provides a new guiding strategy for targeted therapy of UCB.

Microbiota-induced inflammatory responses in bladder tumors promote epithelial-mesenchymal transition and enhanced immune infiltration